102 related articles for article (PubMed ID: 2547372)
1. Antibodies to an NH2-terminal myristoyl glycine moiety can detect NH2-terminal myristoylated proteins in the retrovirus-infected cells.
Shoji S; Tashiro A; Furuishi K; Takenaka O; Kida Y; Horiuchi S; Funakoshi T; Kubota Y
Biochem Biophys Res Commun; 1989 Jul; 162(2):724-32. PubMed ID: 2547372
[TBL] [Abstract][Full Text] [Related]
2. A novel monoclonal antibody to N-myristoyl glycine moiety found a new N-myristoylated HIV-1 p28gag protein in HIV-1-infected cells.
Furuishi K; Misumi S; Shoji S
Biochem Biophys Res Commun; 1996 May; 222(2):344-51. PubMed ID: 8670207
[TBL] [Abstract][Full Text] [Related]
3. A novel antibody against a synthetic NH2-terminal myristoyl glycyl src peptide can detect pp60v-src, the transforming protein of Rous sarcoma virus.
Shoji S; Takenaka O; Kida Y; Matsunaga M; Hayashi M; Horiuchi S; Kubota Y
Mol Cell Probes; 1989 Sep; 3(3):213-24. PubMed ID: 2552299
[TBL] [Abstract][Full Text] [Related]
4. Myristoylated src-oncogene products are potently detected by the monoclonal antibody to the NH2-terminal myristoyl-Gly-Ser-Ser-Lys src-peptide.
Shoji S; Kida Y; Takenaka O; Yoshinaga T; Funakoshi T; Kubota Y
Biochem Biophys Res Commun; 1990 Jul; 170(2):657-64. PubMed ID: 2116793
[TBL] [Abstract][Full Text] [Related]
5. Antimyristoylation of gag proteins in human T-cell leukemia and human immunodeficiency viruses with N-myristoyl glycinal diethylacetal.
Shoji S; Tashiro A; Kubota Y
J Biochem; 1988 May; 103(5):747-9. PubMed ID: 3263365
[TBL] [Abstract][Full Text] [Related]
6. Chemical characterization of p17gag from human immunodeficiency virus as an N-terminally myristoylated protein.
Goddard C; Aquino A; Glazer RI; Felsted RL
Eur J Biochem; 1989 Jun; 182(2):323-6. PubMed ID: 2737204
[TBL] [Abstract][Full Text] [Related]
7. [Function of protein myristoylation in cellular regulation and viral proliferation].
Shoji S; Kubota Y
Yakugaku Zasshi; 1989 Feb; 109(2):71-85. PubMed ID: 2545855
[TBL] [Abstract][Full Text] [Related]
8. N-fatty acyl compounds inhibit myristoyl acylation of pp60v-src and reduce tumorigenicity of Rous sarcoma virus-infected cells.
Shoji S; Tsujita R; Hamuro T; Funakoshi T; Kubota Y
Biochem Int; 1991 Jan; 23(1):15-23. PubMed ID: 1650555
[TBL] [Abstract][Full Text] [Related]
9. Mutation of NH2-terminal glycine of p60src prevents both myristoylation and morphological transformation.
Kamps MP; Buss JE; Sefton BM
Proc Natl Acad Sci U S A; 1985 Jul; 82(14):4625-8. PubMed ID: 2991884
[TBL] [Abstract][Full Text] [Related]
10. Blockage of morphological transformation of chick embryo fibroblasts infected with Rous sarcoma virus by N-myristoyl glycinal diethylacetal in vitro.
Shoji S; Matsunaga M; Tsujita R; Kubota Y
Biochem Int; 1989 Mar; 18(3):509-18. PubMed ID: 2548507
[TBL] [Abstract][Full Text] [Related]
11. Altered membrane association of p60v-src and a murine 63-kDa N-myristoyl protein after incorporation of an oxygen-substituted analog of myristic acid.
Heuckeroth RO; Gordon JI
Proc Natl Acad Sci U S A; 1989 Jul; 86(14):5262-6. PubMed ID: 2501783
[TBL] [Abstract][Full Text] [Related]
12. The first seven amino acids encoded by the v-src oncogene act as a myristylation signal: lysine 7 is a critical determinant.
Kaplan JM; Mardon G; Bishop JM; Varmus HE
Mol Cell Biol; 1988 Jun; 8(6):2435-41. PubMed ID: 2841581
[TBL] [Abstract][Full Text] [Related]
13. Antimyristoylation of GAG proteins in human T-cell lymphotropic and human immunodeficiency viruses by N-myristoyl glycinal diethylacetal.
Shoji S; Tashiro A; Kubota Y
Ann N Y Acad Sci; 1990; 616():97-115. PubMed ID: 1706577
[No Abstract] [Full Text] [Related]
14. Intracellular localization and processing of pp60v-src proteins expressed by two distinct temperature-sensitive mutants of Rous sarcoma virus.
Stoker AW; Kellie S; Wyke JA
J Virol; 1986 Jun; 58(3):876-83. PubMed ID: 3009893
[TBL] [Abstract][Full Text] [Related]
15. pp60v-src tyrosine kinase is expressed and active in sarcoma-free avian embryos microinjected with Rous sarcoma virus.
Howlett AR; Carter VC; Martin GS; Bissell MJ
Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7587-91. PubMed ID: 2845414
[TBL] [Abstract][Full Text] [Related]
16. The HIV-1 Gag precursor Pr55gag synthesized in yeast is myristoylated and targeted to the plasma membrane.
Jacobs E; Gheysen D; Thines D; Francotte M; de Wilde M
Gene; 1989 Jun; 79(1):71-81. PubMed ID: 2673935
[TBL] [Abstract][Full Text] [Related]
17. The 36-kilodalton substrate of pp60v-src is myristylated in a transformation-sensitive manner.
Soric J; Gordon JA
Science; 1985 Nov; 230(4725):563-6. PubMed ID: 2996139
[TBL] [Abstract][Full Text] [Related]
18. Myristic acid, a rare fatty acid, is the lipid attached to the transforming protein of Rous sarcoma virus and its cellular homolog.
Buss JE; Sefton BM
J Virol; 1985 Jan; 53(1):7-12. PubMed ID: 2981363
[TBL] [Abstract][Full Text] [Related]
19. Bacterial expression, purification, and in vitro N-myristoylation of HIV-1 p17gag.
Burnette B; Kahn R; Glover CJ; Felsted RL
Protein Expr Purif; 1992 Oct; 3(5):395-402. PubMed ID: 1458053
[TBL] [Abstract][Full Text] [Related]
20. The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors.
Mervis RJ; Ahmad N; Lillehoj EP; Raum MG; Salazar FH; Chan HW; Venkatesan S
J Virol; 1988 Nov; 62(11):3993-4002. PubMed ID: 3262776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
